```html

Xanthopsia‑Related Dyschromatopsia

What is Xanthopsia‑Related Dyschromatopsia?

Xanthopsia‑related dyschromatopsia is a visual disturbance in which objects appear yellow‑tinted, and the perception of other colors is altered or diminished. The term breaks down into two parts: “xanthopsia” (yellow vision) and “dyschromatopsia” (abnormal color perception). When they occur together, the patient may see the world through a warm, amber hue, have difficulty distinguishing reds from greens, or notice that colours look “washed out.” This condition is not a disease in itself; it is a symptom that can arise from many different ocular, neurological, or systemic problems.<sup>1</sup>

Because colour vision is processed by specialised retinal cells (cones) and then sent to the brain’s visual cortex, disruptions at any point in that pathway can produce a yellowing effect. Recognising xanthopsia‑related dyschromatopsia early can help uncover potentially serious underlying conditions, from medication toxicity to liver disease.

Common Causes

Below are the most frequently reported conditions that can lead to a yellow‑tinged, distorted colour perception:

• Medication side‑effects – especially digoxin, quinine, phenothiazines, and some antibiotics (e.g., ceftriaxone). <sup>2</sup>
• Liver dysfunction – jaundice or cholestasis can raise bilirubin levels, which deposits in the retina and creates a yellow filter. <sup>3</sup>
• Retinal diseases – age‑related macular degeneration (dry or wet form), central serous chorioretinopathy, and retinitis pigmentosa may affect cone function.
• Optic neuritis – inflammation of the optic nerve (often linked to multiple sclerosis) can disturb colour processing.
• Cataracts – particularly nuclear sclerotic cataracts that yellow‑brown the lens, acting like a built‑in filter.
• Neurological lesions – strokes or tumours involving the occipital lobe or visual pathways can produce colour‑loss patterns.
• Vitamin A toxicity or deficiency – excess vitamin A may cause retinal toxicity, while deficiency impairs cone function.
• Diabetic retinopathy – microvascular changes disrupt normal photoreceptor activity.
• Inherited colour‑vision disorders – rare forms of acquired dyschromatopsia can appear later in life after trauma or metabolic disease.
• Exposure to toxic chemicals – solvents, heavy metals (lead, mercury) and certain pesticides can affect the retina.

Each cause has its own mechanism, but the final common pathway is a change in how the eye or brain processes the wavelengths that correspond to yellow and other colours.

Associated Symptoms

Patients with xanthopsia‑related dyschromatopsia often notice other visual or systemic signs:

• Blurred or hazy vision, especially in low‑light conditions.
• Increased glare or difficulty seeing contrasts (e.g., reading black text on a white page).
• Floaters, flashes of light, or a “curtain” over part of the visual field (suggestive of retinal detachment or vascular events).
• Eye pain, redness, or pressure.
• Headaches, especially after reading or working on a computer.
• Systemic symptoms that point to the underlying cause:
  • Jaundice, abdominal pain, or dark urine (liver disease).
  • Palpitations, nausea, or visual “halo” around lights (digoxin toxicity).
  • Weight loss, night sweats, or neurologic deficits (multiple sclerosis or brain tumour).

When to See a Doctor

Colour changes are rarely an emergency on their own, but they can be a red flag for serious disease. Seek professional evaluation promptly if you experience any of the following:

• Sudden onset of yellow vision within minutes to hours.
• Accompanying vision loss, double vision, or a dark “shadow” in part of the visual field.
• Severe headache, nausea, vomiting, or loss of coordination.
• Recent start or dosage change of a medication known to affect colour vision.
• Signs of liver dysfunction (yellow skin, dark urine, itchy skin).
• Persistent symptoms lasting more than a week without improvement.

A timely visit can prevent irreversible damage, especially when the cause is drug toxicity or a progressive retinal disease.

Diagnosis

Diagnosing xanthopsia‑related dyschromatopsia involves a stepwise approach that combines history taking, eye‑specific testing, and systemic work‑up.

1. Detailed Medical & Medication History

• Onset, duration, and progression of the colour change.
• Current prescription, over‑the‑counter, and herbal supplements.
• History of liver disease, diabetes, neurological disorders, or eye surgery.

2. Visual Acuity and Refraction

Standard eye‑chart testing to rule out refractive errors that could mimic colour distortion.

3. Colour Vision Testing

• Ishihara plates – primarily for red‑green defects but can highlight general dyschromatopsia.
• Farnsworth‑Munsell 100 Hue Test – quantifies the severity of colour discrimination loss.
• Goldmann perimetry – maps visual fields to detect focal defects.

4. Fundus Examination

Using slit‑lamp biomicroscopy and dilated retinal inspection to identify cataracts, macular changes, or retinal pigment alterations.

5. Imaging & Laboratory Studies

• Optical Coherence Tomography (OCT) – cross‑sectional view of retinal layers.
• Fluorescein Angiography – evaluates retinal blood flow if vascular disease is suspected.
• MRI of the brain and orbits – indicated when neurological causes (stroke, tumour) are considered.
• Liver function tests (AST, ALT, bilirubin, ALP) – screen for cholestasis or hepatitis.
• Serum digoxin level – if patient is on cardiac glycosides.

6. Toxicology Screening

When exposure to solvents, heavy metals, or other toxins is suspected, blood or urine assays can confirm elevated levels.

Treatment Options

Treatment is directed at the underlying cause; colour perception often improves once the primary problem is addressed.

Medication‑Related Causes

• Stop or substitute the offending drug under physician supervision (e.g., switch from digoxin to an alternative heart‑failure medication).
• Monitor serum drug levels and adjust dosage as needed.

Liver Disease

• Address the hepatic condition – antiviral therapy for hepatitis, lifestyle changes for fatty liver, or surgical intervention for biliary obstruction.
• Supportive care with vitamin‑K, albumin, or lactulose for complications.

Retinal & Lens Disorders

• Cataract surgery – removal of the yellowed lens restores colour fidelity in most cases.
• Anti‑VEGF injections for neovascular age‑related macular degeneration.
• Photocoagulation or photodynamic therapy for central serous chorioretinopathy.

Optic Neuritis & Neurological Causes

• High‑dose intravenous corticosteroids (e.g., methylprednisolone) followed by oral taper for optic neuritis.
• Disease‑specific disease‑modifying therapies for multiple sclerosis.
• Surgical resection or radiotherapy for tumours compressing the visual pathway.

Systemic Toxicities

• Remove exposure to the toxin and provide chelation therapy when indicated (e.g., dimercaprol for arsenic).
• Supportive ophthalmic care – artificial tears, protective sunglasses.

Supportive & Home Measures

• Use high‑contrast settings on computers and phones to compensate for colour loss.
• Wear polarized sunglasses outdoors to reduce glare.
• Maintain a balanced diet rich in lutein, zeaxanthin, omega‑3 fatty acids, and vitamin A to support retinal health.
• Regular eye‑exam schedule—at least once every 1–2 years, or more frequently if you have a known risk factor.

Prevention Tips

While some causes (genetic retinal disease) cannot be prevented, many risk factors are modifiable:

• Medication vigilance – keep an updated list, discuss visual side‑effects with your pharmacist, and never adjust doses on your own.
• Liver health – limit alcohol, maintain a healthy weight, vaccinate against hepatitis A & B, and avoid unnecessary hepatotoxic drugs.
• Protect your eyes – wear safety goggles when handling chemicals, and use UV‑blocking sunglasses outdoors.
• Control systemic diseases – tight glycaemic control for diabetes, blood pressure management for hypertension, and regular cholesterol checks.
• Healthy diet – leafy greens, carrots, fish, and nuts provide antioxidants that combat retinal oxidative stress.
• Regular vision screening – early detection of cataracts, macular changes, or optic nerve inflammation can prevent permanent colour loss.

Emergency Warning Signs

Key Take‑aways

Xanthopsia‑related dyschromatopsia is a yellow‑tinged colour distortion that can signal a wide range of ocular, neurological, or systemic illnesses. Recognising the symptom, understanding its common triggers, and seeking prompt evaluation are essential steps to protect vision and overall health. With appropriate diagnosis and treatment—whether by adjusting medication, managing liver disease, or repairing cataracts—most patients experience substantial improvement in colour perception.

---

Sources:
1. Mayo Clinic. “Colour vision deficiency.” mayoclinic.org.
2. FDA. “Drug safety and visual side effects of digoxin.” fda.gov.
3. American Liver Foundation. “Jaundice and vision changes.” liverfoundation.org.
4. National Eye Institute. “Age‑related macular degeneration.” nei.nih.gov.
5. Cleveland Clinic. “Optic neuritis: symptoms and treatment.” clevelandclinic.org.
6. WHO. “Guidelines for safe use of chemicals in occupational settings.” who.int.

```